CHANGING PRACTICES IN COPD - A NEW PHARMACOLOGICAL TREATMENT ALGORITHM

[1] [Anonymous], 1994, CHEST, V105, P1411

[2] RESPONSE TO INHALED BRONCHODILATORS IN COPD [J]. CHEST, 1987, 91 (05) : S36 - S39

[3] EFFECTS OF SMOKING INTERVENTION AND THE USE OF AN INHALED ANTICHOLINERGIC BRONCHODILATOR ON THE RATE OF DECLINE OF FEV(1) - THE LUNG HEALTH STUDY [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (19): : 1497 - 1505

[4] BARTER CE, 1976, AM REV RESPIR DIS, V113, P305

[5] BONE RC, 1991, J RESP DIS, V12, P727

[6] A COMPARISON OF THE EFFECT OF IPRATROPIUM AND ALBUTEROL IN THE TREATMENT OF CHRONIC OBSTRUCTIVE AIRWAY DISEASE [J]. ARCHIVES OF INTERNAL MEDICINE, 1989, 149 (03) : 544 - 547

[7] THE COURSE AND PROGNOSIS OF DIFFERENT FORMS OF CHRONIC AIRWAYS OBSTRUCTION IN A SAMPLE FROM THE GENERAL-POPULATION [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (21) : 1309 - 1314

[8] ORAL CORTICOSTEROID-THERAPY FOR PATIENTS WITH STABLE CHRONIC OBSTRUCTIVE PULMONARY-DISEASE - A METAANALYSIS [J]. ANNALS OF INTERNAL MEDICINE, 1991, 114 (03) : 216 - 223

[9] SLOWING THE DETERIORATION OF ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY-DISEASE OBSERVED DURING BRONCHODILATOR THERAPY BY ADDING INHALED CORTICOSTEROIDS - A 4-YEAR PROSPECTIVE-STUDY [J]. ANNALS OF INTERNAL MEDICINE, 1993, 118 (10) : 770 - 778

[10] A COMPARISON OF THE BRONCHODILATING EFFECTS OF A BETA-2 ADRENERGIC AGENT (ALBUTEROL) AND AN ANTICHOLINERGIC AGENT (IPRATROPIUM BROMIDE), GIVEN BY AEROSOL ALONE OR IN SEQUENCE [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (12) : 735 - 739

[1] [Anonymous], 1994, CHEST, V105, P1411

[2] RESPONSE TO INHALED BRONCHODILATORS IN COPD [J]. CHEST, 1987, 91 (05) : S36 - S39

[3] EFFECTS OF SMOKING INTERVENTION AND THE USE OF AN INHALED ANTICHOLINERGIC BRONCHODILATOR ON THE RATE OF DECLINE OF FEV(1) - THE LUNG HEALTH STUDY [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (19): : 1497 - 1505

[4] BARTER CE, 1976, AM REV RESPIR DIS, V113, P305

[5] BONE RC, 1991, J RESP DIS, V12, P727

[6] A COMPARISON OF THE EFFECT OF IPRATROPIUM AND ALBUTEROL IN THE TREATMENT OF CHRONIC OBSTRUCTIVE AIRWAY DISEASE [J]. ARCHIVES OF INTERNAL MEDICINE, 1989, 149 (03) : 544 - 547

[7] THE COURSE AND PROGNOSIS OF DIFFERENT FORMS OF CHRONIC AIRWAYS OBSTRUCTION IN A SAMPLE FROM THE GENERAL-POPULATION [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (21) : 1309 - 1314

[8] ORAL CORTICOSTEROID-THERAPY FOR PATIENTS WITH STABLE CHRONIC OBSTRUCTIVE PULMONARY-DISEASE - A METAANALYSIS [J]. ANNALS OF INTERNAL MEDICINE, 1991, 114 (03) : 216 - 223

[9] SLOWING THE DETERIORATION OF ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY-DISEASE OBSERVED DURING BRONCHODILATOR THERAPY BY ADDING INHALED CORTICOSTEROIDS - A 4-YEAR PROSPECTIVE-STUDY [J]. ANNALS OF INTERNAL MEDICINE, 1993, 118 (10) : 770 - 778

[10] A COMPARISON OF THE BRONCHODILATING EFFECTS OF A BETA-2 ADRENERGIC AGENT (ALBUTEROL) AND AN ANTICHOLINERGIC AGENT (IPRATROPIUM BROMIDE), GIVEN BY AEROSOL ALONE OR IN SEQUENCE [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (12) : 735 - 739